Clinical Approach to Heartburn
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of heartburn
Heartburn is one of the most common gastrointestinal symptoms encountered in clinical practice, affecting approximately 20% of adults in Western populations on a weekly basis. In the United States alone, heartburn accounts for over 8 million physician visits annually and represents a significant burden on healthcare resources. The symptom has a substantial impact on quality of life, with studies showing that frequent heartburn can affect sleep quality, work productivity, and overall well-being comparable to other chronic conditions such as heart failure and diabetes.
Definition
Heartburn is a burning sensation or discomfort felt in the retrosternal area, typically rising from the epigastrium toward the neck. It results from the reflux of gastric contents into the esophagus, causing irritation of the esophageal mucosa. Despite its name, heartburn is a gastrointestinal symptom and must be distinguished from cardiac chest pain, which can present similarly.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute/Episodic | Isolated episodes or less than 2 weeks | Dietary indiscretion, alcohol, NSAIDs, stress, overeating | Usually self-limiting; responds to lifestyle modification and antacids |
| Frequent | 2 or more episodes per week for 2-8 weeks | Gastroesophageal reflux disease (GERD), hiatal hernia, medication-induced | Warrants empiric proton pump inhibitor trial; consider evaluation if persistent |
| Chronic | Greater than 8 weeks despite treatment | Refractory GERD, eosinophilic esophagitis, functional heartburn, Barrett esophagus | Requires endoscopic evaluation; consider esophageal function testing |
Classification by Character
Typical Heartburn
Description: Retrosternal burning sensation that rises from the epigastrium toward the throat, often accompanied by acid regurgitation.
Clinical implication: Highly suggestive of gastroesophageal reflux disease; responds well to acid suppression therapy. Positive predictive value for GERD is approximately 80% when both heartburn and regurgitation are present.
Atypical Heartburn
Description: Chest discomfort that may be described as pressure, tightness, or non-burning pain; may radiate to the back, neck, or arms.
Clinical implication: Requires careful differentiation from cardiac causes. Must consider esophageal dysmotility, eosinophilic esophagitis, and functional esophageal disorders. May require more extensive evaluation.
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Postprandial | Occurs within 30-60 minutes after meals, especially large or fatty meals | Gastroesophageal reflux disease; transient lower esophageal sphincter relaxations |
| Nocturnal/Supine | Worsens when lying flat; may wake patient from sleep | GERD with impaired esophageal clearance; hiatal hernia; increased aspiration risk |
| Exertional | Triggered by physical activity or bending forward | May indicate cardiac origin; also seen with large hiatal hernias and increased intra-abdominal pressure |
| Food-Specific | Reproducibly triggered by certain foods (citrus, tomatoes, chocolate, coffee, alcohol, spicy foods) | Dietary triggers causing transient lower esophageal sphincter relaxation or direct mucosal irritation |
| Medication-Related | Temporally associated with medication intake | Drug-induced esophagitis (bisphosphonates, doxycycline, NSAIDs, potassium chloride, iron) |
| Stress-Related | Worsens during periods of psychological stress or anxiety | Functional heartburn; visceral hypersensitivity; may coexist with anxiety disorders |
Associated Symptoms and Their Significance
| Associated Symptom | Frequency in GERD | Clinical Significance |
|---|---|---|
| Acid regurgitation | 60-70% | Highly specific for GERD; sour or bitter taste in mouth |
| Dysphagia | 30-40% | Alarm symptom; may indicate stricture, esophagitis, or malignancy |
| Chronic cough | 20-40% | Extraesophageal manifestation; often nocturnal |
| Hoarseness | 15-20% | Laryngopharyngeal reflux; worse in morning |
| Globus sensation | 25-30% | Sensation of lump in throat; may be functional or related to reflux |
| Waterbrash | 10-15% | Sudden filling of mouth with saliva; vagally-mediated response to acid reflux |
Key Concept: The Heartburn Spectrum
Heartburn represents a spectrum from occasional, benign episodes to chronic disease with complications. The three most important questions to answer are:
- Is this cardiac? — Always consider and exclude cardiac causes in appropriate patients
- Are there alarm features? — Dysphagia, weight loss, bleeding, or anemia require urgent evaluation
- Is this responsive to acid suppression? — Lack of response to proton pump inhibitors suggests alternative diagnoses
Impact on Quality of Life
Why Heartburn Matters
Studies consistently show that frequent heartburn significantly impairs quality of life:
- Sleep disturbance: 75% of patients with nocturnal heartburn report sleep problems
- Work productivity: GERD patients lose an average of 2-3 hours of productive work per week
- Dietary restrictions: Patients often avoid social eating situations
- Psychological impact: Increased rates of anxiety and depression compared to general population
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of heartburn
Heartburn occurs when gastric contents, particularly hydrochloric acid and pepsin, reflux into the esophagus and contact the esophageal mucosa. Unlike the stomach, which is protected by a thick mucus layer and rapid epithelial turnover, the esophageal squamous epithelium has limited defense mechanisms against acid exposure. Understanding the normal anti-reflux barrier and its failure points is essential for diagnosis and management.
The Anti-Reflux Barrier
| Component | Structure | Function |
|---|---|---|
| Lower Esophageal Sphincter (LES) | 3-4 cm segment of tonically contracted smooth muscle at the gastroesophageal junction | Maintains resting pressure of 10-30 mmHg; primary barrier to reflux |
| Crural Diaphragm | Right crus of diaphragm surrounding the esophageal hiatus | Provides external compression; augments LES during inspiration and straining |
| Phrenoesophageal Ligament | Fibrous membrane connecting esophagus to diaphragm | Anchors gastroesophageal junction below diaphragm; maintains anatomic alignment |
| Angle of His | Acute angle between esophagus and gastric fundus | Creates a flap-valve mechanism; compressed by gastric distension |
| Intra-Abdominal Esophageal Segment | 2-3 cm of esophagus below the diaphragm | Exposed to positive abdominal pressure, aiding LES competence |
Primary Mechanisms of Reflux
Transient LES Relaxations (TLESRs)
Mechanism: Vagally-mediated relaxations of the LES lasting 10-60 seconds, occurring independently of swallowing
Trigger: Gastric distension stimulating mechanoreceptors in the gastric fundus
Clinical relevance: Primary mechanism in 70-80% of reflux episodes; target of baclofen therapy
Hypotensive LES
Mechanism: Resting LES pressure less than 10 mmHg, allowing free reflux
Causes: Smooth muscle dysfunction, scleroderma, surgical damage, severe esophagitis
Clinical relevance: Associated with more severe GERD; may require surgical intervention
Hiatal Hernia
Mechanism: Herniation of gastric cardia above diaphragm disrupts anti-reflux barrier
Effects: Separates LES from crural diaphragm; creates acid pocket; impairs clearance
Clinical relevance: Present in 50-90% of patients with erosive esophagitis; size correlates with severity
Esophageal Defense and Clearance Mechanisms
| Mechanism | Normal Function | When Impaired |
|---|---|---|
| Primary Peristalsis | Swallow-initiated contractions clear 90% of refluxed material | Ineffective esophageal motility prolongs acid exposure; seen in 30% of GERD patients |
| Secondary Peristalsis | Distension-triggered contractions clear residual refluxate | Impairment leads to prolonged acid contact time |
| Salivary Neutralization | Bicarbonate-rich saliva (pH 7-8) neutralizes residual acid | Reduced during sleep; impaired in Sjögren syndrome and after radiation |
| Gravity | Upright position promotes clearance | Supine position eliminates gravitational advantage; explains nocturnal symptoms |
| Tissue Resistance | Pre-epithelial (mucus, bicarbonate), epithelial (tight junctions), post-epithelial (blood flow) | Dilated intercellular spaces allow acid penetration; basis of non-erosive reflux disease symptoms |
The Gastric Acid Pocket Phenomenon
Understanding the Acid Pocket
After meals, a layer of unbuffered, highly acidic gastric juice (pH less than 2) forms on top of the food bolus near the gastroesophageal junction. This “acid pocket” is the primary source of postprandial reflux episodes.
- Location: Extends 2-3 cm below to 2 cm above the squamocolumnar junction
- Duration: Persists for 1-2 hours after meals
- In hiatal hernia: Pocket migrates above the diaphragm, increasing reflux potential
- Treatment implication: Explains why alginate-antacid combinations (which float on the acid pocket) provide rapid symptom relief
How Specific Conditions Cause Heartburn
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Gastroesophageal reflux disease (GERD) | Combination of increased TLESRs, impaired clearance, and mucosal sensitivity; acid exposure time greater than 4-6% of 24 hours | Proton pump inhibitors reduce acid production; surgery addresses mechanical barrier |
| Hiatal hernia | Gastric cardia above diaphragm creates reservoir; disrupts crural diaphragm contribution; impairs acid clearance from hernia sac | Large hernias (greater than 3 cm) may require surgical repair; acid pocket targeted by alginates |
| Obesity | Increased intra-abdominal pressure; higher rate of TLESRs; greater prevalence of hiatal hernia; dietary factors | Weight loss improves symptoms in 65% of patients; reduces acid exposure time |
| Pregnancy | Progesterone relaxes LES smooth muscle; increased abdominal pressure from gravid uterus; altered gastric emptying | Lifestyle modifications first; antacids and alginates safe; proton pump inhibitors if severe |
| Scleroderma | Smooth muscle atrophy causes severely hypotensive LES (often less than 5 mmHg); aperistalsis prevents clearance | High-dose proton pump inhibitors essential; severe cases require surgery with fundoplication modification |
| Eosinophilic esophagitis | Eosinophilic inflammation causes mucosal sensitivity; dysmotility; may coexist with GERD | Proton pump inhibitors may be effective in subset; topical steroids for true eosinophilic esophagitis |
| Functional heartburn | Normal acid exposure but visceral hypersensitivity; heightened perception of normal physiologic reflux events | Neuromodulators (tricyclic antidepressants, SSRIs); proton pump inhibitors ineffective |
| Drug-induced esophagitis | Direct mucosal injury from prolonged pill contact; caustic injury from bisphosphonates, doxycycline, NSAIDs, potassium chloride | Proper pill-taking technique; adequate water; avoid supine position after medications |
Factors Affecting Lower Esophageal Sphincter Tone
Factors That Decrease LES Pressure
- Foods: Chocolate, peppermint, fatty foods, alcohol, coffee
- Medications: Calcium channel blockers, nitrates, benzodiazepines, anticholinergics, theophylline, opioids
- Hormones: Progesterone, glucagon, secretin, cholecystokinin
- Other: Smoking, gastric distension
Factors That Increase LES Pressure
- Foods: Protein meals
- Medications: Metoclopramide, cisapride (withdrawn), baclofen
- Hormones: Gastrin, motilin, substance P
- Other: Increased intra-abdominal pressure (acute effect)
Why Nocturnal Reflux Is More Damaging
The Perfect Storm of Nighttime Reflux:
- Loss of gravity: Supine position eliminates gravitational clearance
- Reduced swallowing: Swallow frequency decreases from 25 per hour (awake) to less than 5 per hour (asleep)
- Decreased salivation: Salivary flow nearly ceases during sleep
- Absent protective reflexes: Arousal threshold must be exceeded for protective responses
- Prolonged acid contact: Single reflux episode during sleep may cause 20-30 minutes of acid exposure versus 1-2 minutes when awake
Clinical implication: Nocturnal heartburn is associated with more severe esophagitis, Barrett esophagus, and extraesophageal manifestations.
Often Overlooked Mechanism: Reflux Hypersensitivity
Up to 40% of patients with heartburn symptoms have normal acid exposure on pH monitoring. These patients have either functional heartburn or reflux hypersensitivity, where normal amounts of acid cause abnormal symptom perception. This explains why some patients have persistent symptoms despite adequate acid suppression. The mechanism involves:
- Peripheral sensitization: Upregulation of acid-sensing ion channels (ASICs) and TRPV1 receptors in esophageal afferents
- Central sensitization: Amplified processing of esophageal signals in the central nervous system
- Psychological factors: Anxiety and hypervigilance to visceral sensations
Recognition of this mechanism is crucial to avoid escalating acid suppression in patients who will not benefit.
3. History Taking
A comprehensive approach to eliciting the heartburn history
Red Flags — Require Urgent Evaluation
- Dysphagia — Difficulty swallowing suggests stricture, ring, or malignancy
- Odynophagia — Painful swallowing indicates severe esophagitis or ulceration
- Unintentional weight loss — Greater than 5% body weight; raises concern for malignancy
- Gastrointestinal bleeding — Hematemesis, melena, or iron deficiency anemia
- Persistent vomiting — May indicate gastric outlet obstruction
- Age greater than 55 with new symptoms — Increased risk of Barrett esophagus and adenocarcinoma
- Family history of esophageal or gastric cancer — Warrants earlier endoscopy
- Symptoms suggestive of cardiac origin — Exertional chest pain, radiation to arm/jaw, associated with dyspnea or diaphoresis
Systematic History: The “REFLUX” Approach
Use the mnemonic “REFLUX” to ensure comprehensive history taking:
- R — Region and Radiation: Where exactly is the burning? Does it move upward toward the throat? Any radiation to back, arms, or jaw (cardiac warning)?
- E — Episodes and Duration: How often does this occur? How long has it been happening? How long does each episode last?
- F — Food and Precipitants: What triggers the symptoms? Specific foods, large meals, alcohol, lying down, bending over, exercise?
- L — Lifestyle and Medications: Smoking, alcohol, obesity, medications that worsen reflux or cause esophageal injury? Previous treatments tried?
- U — Underlying Symptoms: Associated regurgitation, dysphagia, cough, hoarseness, dental erosions, weight loss, bleeding?
- X — eXclusion of Cardiac: Any exertional component? Risk factors for coronary artery disease? Associated shortness of breath or diaphoresis?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Gastroesophageal reflux disease (GERD) | Postprandial burning, acid regurgitation, relief with antacids, worse when supine | “Do you ever taste sour or bitter fluid in the back of your throat?” “Does lying flat or bending over make it worse?” |
| Cardiac chest pain (angina) | Exertional, pressure-like, radiation to arm/jaw, associated dyspnea | “Does this burning come on when you walk or climb stairs?” “Do you feel short of breath or sweaty when this happens?” |
| Esophageal motility disorder | Dysphagia to solids and liquids, chest pain with swallowing, food sticking | “Do you have trouble swallowing both liquids and solid foods?” “Does food ever feel stuck in your chest?” |
| Eosinophilic esophagitis | Young male, atopic history, intermittent dysphagia, food impaction | “Have you ever had food get completely stuck requiring emergency removal?” “Do you have asthma, eczema, or food allergies?” |
| Peptic ulcer disease | Epigastric pain, relationship to meals, NSAID use, Helicobacter pylori risk | “Is the pain more in the pit of your stomach rather than behind the breastbone?” “Do you take ibuprofen, aspirin, or naproxen regularly?” |
| Drug-induced esophagitis | Acute onset, odynophagia, temporal relationship to new medication | “Did this start after beginning a new medication?” “Do you take pills with a full glass of water and stay upright afterward?” |
| Functional heartburn | Symptoms despite adequate proton pump inhibitor therapy, normal endoscopy, stress-related | “Have you had an endoscopy that was normal?” “Do symptoms worsen during stressful periods?” “Does acid medication help at all?” |
| Esophageal cancer | Progressive dysphagia, weight loss, older age, smoking/alcohol history, Barrett esophagus | “Has swallowing become progressively more difficult over weeks to months?” “Have you lost weight without trying?” |
Characterizing the Heartburn
| Characteristic | Typical GERD Pattern | Concerning Pattern |
|---|---|---|
| Location | Retrosternal, rising from epigastrium to throat | Left-sided chest, radiation to arm/jaw (cardiac); epigastric only (peptic ulcer) |
| Quality | Burning, warm sensation | Pressure, squeezing, tightness (cardiac); sharp, stabbing (musculoskeletal) |
| Timing | 30-60 minutes after meals, nocturnal when supine | With exertion (cardiac); constant regardless of meals (malignancy, motility) |
| Duration | Minutes to 1-2 hours, intermittent | Seconds (esophageal spasm); hours of continuous pain (esophagitis, ulcer) |
| Relieving factors | Antacids, proton pump inhibitors, upright position, belching | Rest or nitroglycerin (cardiac); nothing helps (functional, malignancy) |
Medication and Social History
Medications That Cause or Worsen Heartburn
Decrease LES Pressure:
- Calcium channel blockers — Smooth muscle relaxation
- Nitrates — Smooth muscle relaxation
- Benzodiazepines — Central and peripheral effects
- Anticholinergics — Reduce LES tone and gastric emptying
- Theophylline — Relaxes LES smooth muscle
- Opioids — Decrease LES pressure and gastric motility
Direct Esophageal Injury:
- Bisphosphonates — Severe esophagitis if not taken properly
- Doxycycline and tetracycline — Pill esophagitis
- NSAIDs — Direct mucosal injury
- Potassium chloride — Caustic injury
- Iron supplements — Local irritation
- Quinidine — Direct toxic effect
Social and Lifestyle History
- Smoking: Reduces LES pressure, impairs salivation, increases esophageal cancer risk with Barrett esophagus
- Alcohol: Direct irritant, reduces LES pressure, increases cancer risk
- Obesity: Strong risk factor; BMI greater than 30 doubles GERD risk; central adiposity most important
- Diet: Large meals, eating before bed, fatty foods, chocolate, peppermint, citrus, tomatoes, coffee
- Occupation: Jobs requiring bending, heavy lifting, or tight clothing around waist
- Stress: Associated with symptom perception; may indicate functional component
- Sleep position: Left lateral decubitus reduces nocturnal reflux compared to right side or supine
Previous Treatments
- Response to antacids (suggests acid-related)
- Response to proton pump inhibitors (dose, duration, timing)
- Previous endoscopy results
- Any surgical history (fundoplication, bariatric surgery)
Assessing Response to Proton Pump Inhibitor Therapy
The Proton Pump Inhibitor Test
Response to an empiric proton pump inhibitor trial is a key diagnostic feature:
- Good response (greater than 50% improvement): Supports GERD diagnosis; sensitivity 78%, specificity 54%
- Partial response: May indicate inadequate dosing, poor compliance, non-acid reflux, or overlapping pathology
- No response: Consider functional heartburn, eosinophilic esophagitis, achalasia, or incorrect diagnosis
Important: Ask about timing of proton pump inhibitor dosing — should be taken 30-60 minutes before meals for optimal efficacy.
Screening for Extraesophageal Manifestations
| Symptom | Mechanism | Key Questions |
|---|---|---|
| Chronic cough | Microaspiration; vagal reflex from distal esophagus | “Do you have a cough that is worse at night or after meals?” “Has your cough persisted despite treatment for other causes?” |
| Hoarseness | Laryngopharyngeal reflux causing laryngeal inflammation | “Is your voice worse in the morning?” “Do you frequently clear your throat?” |
| Asthma symptoms | Microaspiration; vagally-mediated bronchoconstriction | “Does your wheezing or shortness of breath worsen after meals or at night?” |
| Dental erosions | Acid damage to tooth enamel | “Has your dentist mentioned erosion of your teeth?” “Do you have increased tooth sensitivity?” |
| Globus sensation | Pharyngeal irritation; may be functional | “Do you feel like there is a lump in your throat that does not affect swallowing?” |
4. Physical Examination
A systematic head-to-toe approach for heartburn
Systematic Framework: Use the “Head to Extremities” approach for complete examination of patients presenting with heartburn. While the physical examination is often normal in uncomplicated gastroesophageal reflux disease, examination is essential to identify red flags, exclude cardiac causes, and detect complications.
General Inspection
- Appearance: Comfortable versus distressed; note if symptoms are present during examination
- Body habitus: Obesity is a major risk factor; estimate BMI visually; note central adiposity
- Pallor: May indicate anemia from chronic gastrointestinal blood loss
- Cachexia or muscle wasting: Raises concern for malignancy
- Diaphoresis: May suggest cardiac etiology or severe pain
- Respiratory distress: Consider cardiac cause or severe aspiration
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Blood Pressure | Hypertension, hypotension, orthostatic changes | Hypertension: cardiovascular risk factor; Hypotension: may indicate bleeding or dehydration from vomiting |
| Heart Rate | Tachycardia, bradycardia, irregularity | Tachycardia: pain, anxiety, bleeding, or cardiac event; Irregularity: arrhythmia evaluation needed |
| Respiratory Rate | Tachypnea | May indicate cardiac cause, aspiration, or severe distress |
| Oxygen Saturation | Hypoxemia | Low saturation suggests cardiac cause, aspiration pneumonia, or pulmonary disease |
| Temperature | Fever | May indicate infectious esophagitis, aspiration pneumonia, or mediastinitis (perforation) |
| Weight and BMI | Obesity (BMI greater than 30), recent weight loss | Obesity: major GERD risk factor; Weight loss: alarm feature for malignancy |
Head and Neck Examination
Oral Cavity
- Dental erosions: Loss of enamel on lingual surfaces of teeth (pathognomonic for chronic reflux)
- Halitosis: May indicate reflux or poor oral hygiene
- Oral ulcers: May suggest systemic disease (Behçet, Crohn)
- Angular cheilitis: May indicate iron deficiency from chronic blood loss
- Glossitis: Smooth, red tongue suggests nutritional deficiency
- Oropharyngeal erythema: Laryngopharyngeal reflux
Neck
- Lymphadenopathy: Cervical or supraclavicular nodes raise concern for malignancy (Virchow node on left)
- Thyroid: Thyroid disease can affect esophageal motility
- Jugular venous distension: May indicate heart failure (cardiac cause of symptoms)
- Carotid bruits: Marker for atherosclerotic disease and cardiac risk
Cardiovascular Examination
Critical Step: Exclude Cardiac Cause
Cardiovascular examination is essential in all patients presenting with “heartburn” to exclude cardiac chest pain:
- Inspection: Jugular venous pressure elevation, peripheral edema
- Palpation: Displaced apex beat, heaves, thrills
- Auscultation: S3 or S4 gallop (heart failure), new murmurs, pericardial rub
- Peripheral pulses: Diminished or asymmetric pulses suggest vascular disease
Remember: Angina and GERD can coexist. A normal cardiovascular examination does not exclude cardiac disease in high-risk patients.
Respiratory Examination
Inspection
- Respiratory rate and pattern
- Use of accessory muscles
- Barrel chest (suggests COPD, which commonly coexists with GERD)
Auscultation
| Finding | Description | Clinical Significance |
|---|---|---|
| Wheezing | High-pitched musical sounds, typically expiratory | May indicate reflux-triggered asthma or COPD exacerbation |
| Crackles | Fine or coarse discontinuous sounds | May suggest aspiration pneumonia or heart failure |
| Decreased breath sounds | Reduced air entry in lung fields | May indicate pleural effusion or consolidation |
| Stridor | High-pitched inspiratory sound | Upper airway involvement; consider severe laryngopharyngeal reflux or other pathology |
Abdominal Examination
Inspection
- Central obesity: Measure waist circumference if possible (greater than 102 cm in men, greater than 88 cm in women is significant)
- Distension: May indicate ascites, obstruction, or large hiatal hernia
- Surgical scars: Previous abdominal or anti-reflux surgery
- Visible masses: Epigastric mass raises concern for malignancy
Palpation
- Epigastric tenderness: Common in GERD, peptic ulcer disease, gastritis
- Hepatomegaly: May indicate metastatic disease or liver pathology
- Masses: Epigastric or left upper quadrant mass concerning for malignancy
- Ascites: May indicate advanced malignancy or liver disease
Percussion and Auscultation
- Succussion splash: Heard more than 3 hours after eating suggests gastric outlet obstruction or gastroparesis
- Shifting dullness: Indicates ascites
- Bowel sounds: Absent or high-pitched tinkling may indicate obstruction
Skin and Extremities
| Finding | Location | Clinical Significance |
|---|---|---|
| Pallor | Conjunctivae, palmar creases, nail beds | Suggests anemia from chronic gastrointestinal blood loss |
| Skin thickening | Face, hands, forearms | Scleroderma — associated with severe GERD and esophageal dysmotility |
| Telangiectasias | Face, lips, hands | Scleroderma or hereditary hemorrhagic telangiectasia |
| Raynaud phenomenon | Fingers, toes | Associated with scleroderma and other connective tissue diseases |
| Digital ulcers or sclerodactyly | Fingertips | Strong indicator of systemic sclerosis |
| Peripheral edema | Lower extremities | May indicate heart failure (cardiac cause of symptoms) or hypoalbuminemia |
| Clubbing | Fingers | May suggest malignancy, chronic lung disease, or cardiac disease |
Expected Findings by Etiology
| Condition | General Appearance | Key Physical Findings | Examination Clues |
|---|---|---|---|
| Uncomplicated GERD | Usually well; may be obese | Often entirely normal | Obesity, dental erosions on lingual surfaces |
| Erosive esophagitis | Well to mildly uncomfortable | Usually normal; may have epigastric tenderness | Similar to uncomplicated GERD |
| Barrett esophagus | Well appearing | Normal examination | No specific findings; diagnosed by endoscopy |
| Esophageal stricture | May have weight loss | Signs of malnutrition possible | Difficulty swallowing during examination if severe |
| Esophageal cancer | Cachexia, weight loss | Lymphadenopathy, hepatomegaly, ascites | Virchow node (left supraclavicular), Sister Mary Joseph nodule (umbilical) |
| Scleroderma esophagus | Skin changes of systemic sclerosis | Sclerodactyly, facial tightening, telangiectasias | Raynaud phenomenon, digital ulcers, calcinosis |
| Cardiac chest pain | May appear distressed | Diaphoresis, dyspnea, abnormal heart sounds | Elevated JVP, S3/S4, peripheral edema, abnormal vital signs |
| Eosinophilic esophagitis | Young, often male, atopic features | Usually normal; may have eczema, allergic rhinitis signs | Atopic dermatitis, nasal mucosal swelling |
Important Teaching Point
Normal examination is COMMON in heartburn! The majority of patients with gastroesophageal reflux disease, including those with erosive esophagitis and even Barrett esophagus, will have completely normal physical examination findings. The physical examination in heartburn serves three critical purposes:
- Identify red flags: Weight loss, lymphadenopathy, abdominal masses suggesting malignancy
- Exclude cardiac cause: Essential in patients with risk factors or atypical features
- Detect systemic disease: Signs of scleroderma, connective tissue disease, or other conditions affecting the esophagus
A normal physical examination does not exclude significant pathology and should not delay appropriate investigation in the presence of alarm symptoms.
Special Examination Maneuvers
| Maneuver | Technique | Purpose |
|---|---|---|
| Supine position test | Have patient lie flat and observe for symptom reproduction | Demonstrates postural component of reflux |
| Forward bending | Ask patient to bend forward at the waist | May reproduce symptoms by increasing intra-abdominal pressure |
| Orthostatic vital signs | Measure blood pressure and heart rate lying and standing | Detect volume depletion from vomiting or occult bleeding |
| Epigastric palpation during inspiration | Deep palpation of epigastrium while patient takes deep breath | May elicit tenderness from hiatal hernia or gastric pathology |
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute or Episodic Heartburn
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Gastroesophageal reflux disease (GERD) | Postprandial burning, acid regurgitation, relief with antacids, worse supine | Dysphagia, weight loss, bleeding |
| COMMON | Dietary indiscretion | Clear temporal relationship to trigger foods, alcohol, large meals; self-limiting | None if isolated episode |
| COMMON | Functional dyspepsia | Epigastric discomfort, early satiety, bloating; normal endoscopy | Weight loss, persistent vomiting |
| LESS COMMON (approximately 20%) | Drug-induced esophagitis | Acute onset odynophagia, temporal relationship to medication; bisphosphonates, doxycycline, NSAIDs, potassium chloride | Severe odynophagia, inability to swallow |
| LESS COMMON | Acute gastritis | Epigastric burning, nausea, NSAID or alcohol use | Hematemesis, melena |
| LESS COMMON | Peptic ulcer disease | Epigastric pain, may improve or worsen with food; NSAID use, Helicobacter pylori infection | Bleeding, perforation signs |
| UNCOMMON BUT SERIOUS (approximately 10%) | Acute coronary syndrome | Exertional, pressure-like, radiation to arm/jaw, dyspnea, diaphoresis; cardiac risk factors | All presentations are red flags |
| UNCOMMON BUT SERIOUS | Esophageal perforation | Severe chest pain after vomiting (Boerhaave syndrome), recent instrumentation, subcutaneous emphysema | Fever, shock, mediastinal air |
| UNCOMMON BUT SERIOUS | Infectious esophagitis | Immunocompromised patient, odynophagia, oral thrush (Candida); HIV, chemotherapy, transplant | Severe odynophagia, fever, inability to swallow |
Chronic Heartburn (Greater Than 8 Weeks)
Step-by-Step Approach to Chronic Heartburn:
- Step 1: Rule out alarm features — dysphagia, weight loss, bleeding, anemia, age greater than 55 with new symptoms
- Step 2: Assess response to proton pump inhibitor therapy — responders likely have acid-related disease
- Step 3: Consider the “Big Three” — GERD, functional heartburn, and eosinophilic esophagitis account for most chronic cases
- Step 4: If proton pump inhibitor-refractory, investigate with endoscopy and consider esophageal function testing
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Gastroesophageal reflux disease (non-erosive) | 50-60% of chronic heartburn | Typical symptoms, responds to proton pump inhibitors, normal or minimal endoscopic findings |
| COMMON | Erosive esophagitis | 30-40% of GERD patients | Visible mucosal breaks on endoscopy; Los Angeles classification A-D |
| COMMON | Hiatal hernia | Present in 50-90% of erosive esophagitis | Often asymptomatic; size correlates with reflux severity |
| LESS COMMON | Functional heartburn | 10-15% of chronic heartburn | Normal acid exposure, no symptom-reflux correlation; proton pump inhibitor-refractory; Rome IV criteria |
| LESS COMMON | Reflux hypersensitivity | 5-10% of chronic heartburn | Normal acid exposure but positive symptom-reflux correlation; partial proton pump inhibitor response |
| LESS COMMON | Eosinophilic esophagitis | 5-10% of proton pump inhibitor-refractory cases | Young males, atopic history, dysphagia, food impaction; greater than 15 eosinophils per high-power field on biopsy |
| LESS COMMON | Barrett esophagus | 10-15% of chronic GERD patients | Intestinal metaplasia on biopsy; salmon-colored mucosa on endoscopy; increased cancer risk |
| LESS COMMON | Esophageal motility disorders | 5% of chronic heartburn | Dysphagia to solids and liquids, chest pain; achalasia, diffuse esophageal spasm, jackhammer esophagus |
| UNCOMMON | Esophageal stricture (peptic) | 5-10% of severe GERD | Progressive solid food dysphagia, history of long-standing reflux |
| UNCOMMON | Scleroderma esophagus | Rare in general population | Severe reflux, skin changes, Raynaud phenomenon; hypotensive lower esophageal sphincter, aperistalsis |
| UNCOMMON BUT SERIOUS | Esophageal adenocarcinoma | Less than 1% of chronic GERD | Progressive dysphagia, weight loss, Barrett esophagus history; rising incidence |
| UNCOMMON BUT SERIOUS | Gastric cancer | Rare | Epigastric discomfort, early satiety, weight loss, anemia; more common in Asian populations |
Anatomical Approach to Heartburn
Esophageal Causes
Gastroesophageal reflux disease
Erosive esophagitis
Barrett esophagus
Eosinophilic esophagitis
Esophageal motility disorders
Esophageal stricture
Esophageal cancer
Infectious esophagitis
Drug-induced esophagitis
Gastric Causes
Peptic ulcer disease
Gastritis
Gastroparesis
Gastric cancer
Hiatal hernia
Helicobacter pylori infection
Cardiac Causes
Angina pectoris
Acute coronary syndrome
Pericarditis
Aortic dissection (rare)
Other Causes
Functional heartburn
Reflux hypersensitivity
Biliary disease
Chronic pancreatitis
Musculoskeletal chest pain
Anxiety and somatization
Drug-Induced Heartburn and Esophagitis
| Drug or Drug Class | Mechanism | Characteristics | Prevention and Management |
|---|---|---|---|
| Bisphosphonates (alendronate, risedronate) | Direct caustic injury to esophageal mucosa | Severe odynophagia, retrosternal pain; ulceration typically in mid-esophagus | Take with full glass of water; remain upright 30-60 minutes; consider IV formulation if recurrent |
| Doxycycline and tetracycline | Direct chemical injury; pill dissolves and adheres to mucosa | Acute onset odynophagia; often in young patients taking for acne | Take with full glass of water; avoid lying down after; take with food (except tetracycline) |
| NSAIDs (ibuprofen, naproxen, aspirin) | Prostaglandin inhibition impairs mucosal defense; direct topical injury | Heartburn, epigastric pain, ulceration; may cause bleeding | Take with food; consider proton pump inhibitor co-therapy; use lowest effective dose |
| Potassium chloride | Hyperosmolar injury to mucosa | Severe esophagitis, ulceration; more common with slow-release formulations | Take with large volume of fluid; avoid if esophageal compression or dysmotility |
| Iron supplements | Direct oxidative injury to mucosa | Heartburn, nausea, epigastric discomfort | Take with food (reduces absorption); consider alternate formulations |
| Calcium channel blockers | Reduce lower esophageal sphincter pressure | Worsen existing GERD; dose-dependent effect | Consider alternative antihypertensive if GERD is problematic |
| Nitrates | Smooth muscle relaxation reduces lower esophageal sphincter pressure | Worsen existing GERD | Optimize GERD treatment; timing adjustments may help |
| Anticholinergics | Reduce lower esophageal sphincter pressure; delay gastric emptying | Worsen reflux symptoms | Review medication necessity; consider alternatives |
| Opioids | Reduce lower esophageal sphincter pressure; delay gastric emptying | Chronic use worsens GERD | Use lowest effective dose; consider prokinetic agents |
| Quinidine | Direct toxic effect on esophageal mucosa | Esophageal ulceration | Take with adequate fluid; monitor for symptoms |
Proton Pump Inhibitor-Refractory Heartburn: Special Considerations
When Proton Pump Inhibitors Do Not Work
Up to 40% of patients have persistent symptoms despite proton pump inhibitor therapy. Consider:
- Inadequate therapy: Wrong timing (should be 30-60 minutes before meals), insufficient dose, poor compliance
- Weakly acidic or non-acid reflux: Bile reflux, volume reflux; detected on impedance-pH monitoring
- Functional heartburn: Normal acid exposure, no symptom correlation; requires neuromodulation
- Reflux hypersensitivity: Normal acid exposure but symptoms correlate with reflux events
- Eosinophilic esophagitis: Requires biopsy for diagnosis; treat with topical steroids or elimination diet
- Delayed gastric emptying: Gastroparesis worsens reflux; consider prokinetics
- Wrong diagnosis: Achalasia, esophageal spasm, cardiac disease, functional dyspepsia
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Burning with acid regurgitation, worse after meals and supine | Gastroesophageal reflux disease | Empiric proton pump inhibitor trial; endoscopy if alarm features or refractory |
| Exertional chest discomfort with dyspnea in patient with cardiac risk factors | Angina pectoris or acute coronary syndrome | ECG, troponin, cardiology evaluation urgently |
| Young male with atopy, intermittent dysphagia, food impaction history | Eosinophilic esophagitis | Endoscopy with esophageal biopsies (minimum 6 samples) |
| Acute odynophagia after starting bisphosphonate, doxycycline, or NSAID | Drug-induced esophagitis | Stop offending medication; endoscopy if severe or not improving |
| Progressive solid food dysphagia with long-standing heartburn | Peptic stricture or esophageal cancer | Urgent endoscopy with biopsy |
| Skin thickening, Raynaud phenomenon, severe reflux | Scleroderma esophagus | Rheumatology referral; high-dose proton pump inhibitor; esophageal manometry |
| Normal endoscopy, normal pH monitoring, proton pump inhibitor-refractory | Functional heartburn | Neuromodulator therapy (tricyclic antidepressant, SSRI); psychological support |
| Heartburn with dysphagia to both solids and liquids | Esophageal motility disorder (achalasia, spasm) | Barium swallow; esophageal manometry |
| Immunocompromised patient with odynophagia and oral thrush | Candida esophagitis | Endoscopy; empiric fluconazole if high clinical suspicion |
| Weight loss, anemia, age greater than 55 with new symptoms | Esophageal or gastric malignancy | Urgent endoscopy with biopsy |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The diagnosis of typical gastroesophageal reflux disease is primarily clinical, and most patients can be managed with an empiric proton pump inhibitor trial without initial investigation. However, investigations are essential when alarm features are present, symptoms are refractory, or the diagnosis is uncertain.
When to Investigate
Indications for Investigation
Urgent Endoscopy Required
- Dysphagia or odynophagia
- Unintentional weight loss (greater than 5%)
- Gastrointestinal bleeding (hematemesis, melena)
- Iron deficiency anemia
- Persistent vomiting
- Palpable mass or lymphadenopathy
Endoscopy Recommended
- Age greater than 55 with new-onset symptoms
- Symptoms refractory to 8 weeks of proton pump inhibitor therapy
- Multiple risk factors for Barrett esophagus
- Prior to anti-reflux surgery
- Recurrent symptoms after successful treatment
Baseline Investigations for Chronic or Atypical Heartburn
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Detect anemia from chronic blood loss | Low hemoglobin, microcytic indices suggesting iron deficiency | Anemia is an alarm feature requiring endoscopy |
| Iron studies | Confirm iron deficiency if anemia present | Low ferritin, low iron, high total iron-binding capacity | Iron deficiency without obvious cause warrants upper and lower endoscopy |
| Liver function tests | Exclude biliary or hepatic disease | Elevated alkaline phosphatase, gamma-glutamyl transferase (biliary); transaminases (hepatic) | Biliary colic can mimic heartburn |
| Helicobacter pylori testing | Identify infection that may cause dyspepsia | Positive urea breath test, stool antigen, or serology | Test and treat in patients with dyspepsia; must stop proton pump inhibitor 2 weeks before breath test |
| ECG | Exclude cardiac cause in appropriate patients | ST changes, T wave inversions, Q waves, arrhythmias | Essential in patients with cardiac risk factors or atypical features |
| Chest radiograph | Exclude pulmonary disease; may show large hiatal hernia | Retrocardiac mass (large hiatal hernia), pulmonary infiltrates | Not routinely needed but useful if respiratory symptoms present |
Upper Gastrointestinal Endoscopy (Esophagogastroduodenoscopy)
The Gold Standard for Mucosal Evaluation
Endoscopy allows direct visualization of the esophageal mucosa and enables biopsy for histological diagnosis.
- Sensitivity for erosive esophagitis: Greater than 95%
- Findings in GERD: Normal (50-70%), erosive esophagitis (30-40%), Barrett esophagus (10-15% of those with erosive disease)
- Los Angeles Classification: Grade A (mucosal breaks less than 5 mm), Grade B (greater than 5 mm without confluence), Grade C (confluence less than 75% circumference), Grade D (greater than 75% circumference)
| Endoscopic Finding | Description | Clinical Significance | Management Implication |
|---|---|---|---|
| Normal esophagus | No visible mucosal abnormalities | Non-erosive reflux disease, functional heartburn, or reflux hypersensitivity | Consider pH monitoring if diagnosis uncertain; empiric proton pump inhibitor may still be effective |
| Erosive esophagitis | Mucosal breaks visible; graded A-D by Los Angeles classification | Confirms acid-related mucosal damage | Proton pump inhibitor therapy for 8 weeks; repeat endoscopy for Grade C/D to confirm healing |
| Barrett esophagus | Salmon-colored mucosa extending above gastroesophageal junction | Intestinal metaplasia; premalignant condition | Biopsy required; surveillance program based on dysplasia grade |
| Peptic stricture | Narrowing of esophageal lumen, typically distal | Complication of chronic reflux | Endoscopic dilation; long-term proton pump inhibitor therapy |
| Schatzki ring | Thin mucosal ring at squamocolumnar junction | May cause intermittent dysphagia | Dilation if symptomatic; often associated with hiatal hernia |
| Eosinophilic esophagitis findings | Rings (trachealization), furrows, white exudates, strictures | Suggests eosinophilic esophagitis | Must take biopsies (at least 6 from different levels); greater than 15 eosinophils per high-power field diagnostic |
| Hiatal hernia | Gastric cardia above diaphragmatic hiatus | Contributes to reflux mechanism; size correlates with disease severity | Medical management first; surgical repair for large hernias with refractory symptoms |
| Esophageal mass | Visible tumor or nodular mucosa | May represent adenocarcinoma or squamous cell carcinoma | Multiple biopsies; staging investigations; oncology referral |
Targeted Investigations by Suspected Etiology
If Suspecting Proton Pump Inhibitor-Refractory GERD
First-Line Tests
- Upper endoscopy: Exclude erosive esophagitis, Barrett esophagus, eosinophilic esophagitis, or alternative diagnosis
- Esophageal biopsies: Minimum 6 samples from proximal and distal esophagus for eosinophil count; look for reflux changes (basal cell hyperplasia, papillary elongation)
Second-Line Tests
- Ambulatory pH monitoring (off proton pump inhibitor): Quantifies acid exposure; DeMeester score greater than 14.7 or acid exposure time greater than 6% abnormal
- Impedance-pH monitoring: Detects both acid and non-acid reflux; symptom correlation (symptom index greater than 50%, symptom association probability greater than 95%)
- Esophageal manometry: Excludes motility disorders; required before anti-reflux surgery
If Suspecting Motility Disorder
First-Line Tests
- Barium swallow: May show bird-beak appearance (achalasia), corkscrew esophagus (spasm), dilated esophagus
- Upper endoscopy: Exclude mechanical obstruction; food retention suggests achalasia
Second-Line Tests
- High-resolution esophageal manometry: Gold standard for motility disorders; Chicago Classification v4.0
- Timed barium swallow: Assesses esophageal emptying; useful for monitoring achalasia treatment
- Endoscopic ultrasound: If pseudoachalasia (malignancy) suspected
If Suspecting Cardiac Cause
First-Line Tests
- ECG: ST-T changes, Q waves, arrhythmias
- Troponin: If acute coronary syndrome suspected; serial measurements
- Chest radiograph: Cardiomegaly, pulmonary congestion
Second-Line Tests
- Exercise stress testing: For stable patients with exertional symptoms
- Stress echocardiography or nuclear imaging: If ECG uninterpretable or intermediate risk
- Coronary angiography: If high-risk features or positive non-invasive testing
Empiric Treatment Trials as Diagnostic Tools
The Proton Pump Inhibitor Test
Response to empiric proton pump inhibitor therapy is a practical diagnostic tool for suspected GERD:
- Protocol: Double-dose proton pump inhibitor (for example, omeprazole 40 mg or equivalent) for 2-4 weeks
- Positive response: Greater than 50% symptom improvement supports GERD diagnosis
- Sensitivity: 78% | Specificity: 54%
- Limitations: False positives (placebo response, functional improvement); false negatives (inadequate dosing, non-acid reflux, wrong diagnosis)
Important: Ensure correct timing of proton pump inhibitor dosing — 30-60 minutes before the first meal of the day for optimal efficacy.
| Empiric Trial | Protocol | Tests For | Interpretation |
|---|---|---|---|
| Proton pump inhibitor trial | Double-dose proton pump inhibitor for 2-4 weeks | Acid-related disease (GERD) | Response suggests GERD; lack of response warrants investigation |
| Proton pump inhibitor optimization | Correct timing, twice-daily dosing, or switch proton pump inhibitor | Inadequate acid suppression | Response to optimization suggests GERD with suboptimal initial therapy |
| Histamine-2 receptor antagonist at bedtime | Add famotidine 20-40 mg at bedtime to proton pump inhibitor | Nocturnal acid breakthrough | Response suggests nocturnal acid secretion; may develop tachyphylaxis |
| Alginate-antacid trial | Alginate-containing antacid after meals and at bedtime | Postprandial acid pocket | Rapid relief suggests mechanical reflux; adjunct to proton pump inhibitor |
| Tricyclic antidepressant trial | Low-dose amitriptyline or nortriptyline (10-25 mg at bedtime) for 4-8 weeks | Functional heartburn, esophageal hypersensitivity | Response suggests visceral hypersensitivity component |
Esophageal Function Testing: When and Which Test
| Test | Indications | Key Information Provided | Practical Points |
|---|---|---|---|
| Ambulatory pH monitoring (catheter or wireless) | Proton pump inhibitor-refractory symptoms; preoperative evaluation; atypical symptoms | Total acid exposure time; number of reflux episodes; symptom correlation | Perform OFF proton pump inhibitor (7 days) if diagnosing GERD; ON proton pump inhibitor if assessing refractory symptoms |
| Combined impedance-pH monitoring | Suspected non-acid or weakly acidic reflux; proton pump inhibitor-refractory on therapy | Detects all reflux (acid, weakly acid, non-acid); bolus clearance; symptom correlation | More comprehensive than pH alone; essential for patients on proton pump inhibitor therapy |
| High-resolution esophageal manometry | Dysphagia with normal endoscopy; preoperative evaluation; suspected motility disorder | Lower esophageal sphincter pressure and relaxation; esophageal body peristalsis; Chicago Classification diagnosis | Required before anti-reflux surgery to exclude achalasia and assess peristaltic reserve |
| Barium swallow | Dysphagia; suspected stricture; evaluate hiatal hernia size; suspected motility disorder | Anatomical information; hernia size; strictures; gross motility abnormalities | Less sensitive than endoscopy for mucosal disease; useful for anatomical assessment |
Investigation Algorithm Summary
Stepwise Approach to Investigating Heartburn:
- Typical symptoms, no alarm features, age less than 55: Empiric proton pump inhibitor trial (no initial investigation required)
- Alarm features present: Urgent upper endoscopy with biopsies
- Age greater than 55 with new symptoms: Endoscopy recommended even without alarm features
- Proton pump inhibitor-refractory (after 8 weeks): Upper endoscopy with biopsies → if normal, consider impedance-pH monitoring
- Dysphagia with normal endoscopy: Barium swallow → high-resolution manometry
- Preoperative evaluation for anti-reflux surgery: Endoscopy + high-resolution manometry + pH monitoring (if not already done)
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Chest pain with exertional component, dyspnea, diaphoresis, or cardiac risk factors | EMERGENT | ECG, troponin, cardiology evaluation; do not assume gastrointestinal cause until cardiac excluded |
| Severe chest pain after forceful vomiting with subcutaneous emphysema | EMERGENT | Suspect Boerhaave syndrome (esophageal perforation); urgent CT chest with contrast; surgical consultation |
| Complete dysphagia (cannot swallow saliva) | EMERGENT | Suspect food impaction or high-grade obstruction; urgent endoscopy within 24 hours |
| Hematemesis or melena with hemodynamic instability | EMERGENT | Resuscitation, IV proton pump inhibitor, urgent endoscopy; blood products as needed |
| Progressive solid food dysphagia with weight loss | URGENT | Endoscopy within 2 weeks to exclude malignancy or high-grade stricture |
| New heartburn in patient over 55 years old | URGENT | Endoscopy recommended to exclude Barrett esophagus and malignancy; schedule within 4 weeks |
| Odynophagia with recent medication initiation | URGENT | Stop offending medication; endoscopy if severe or not improving within 1 week |
| Typical heartburn without alarm features in young patient | ROUTINE | Lifestyle modification and empiric proton pump inhibitor trial; investigate if refractory |
| Chronic stable heartburn controlled on proton pump inhibitor | ROUTINE | Periodic reassessment; attempt step-down therapy; consider endoscopy for Barrett screening if long duration and risk factors |
Step 2: Classify by Duration and Response
Acute/Episodic (Less Than 2 Weeks)
Action: Lifestyle modification, antacids, or short-term proton pump inhibitor
Follow-up: If resolves, no further workup needed
Proceed to Algorithm A
Frequent (2 or More Episodes per Week)
Action: Empiric proton pump inhibitor trial for 4-8 weeks
Follow-up: Assess response; investigate if refractory
Proceed to Algorithm B
Chronic/Refractory (Greater Than 8 Weeks)
Action: Endoscopy with biopsies; consider esophageal function testing
Follow-up: Management based on findings
Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute or Episodic Heartburn
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Burning after large meal, alcohol, or trigger foods; no alarm features | Dietary-induced reflux | Lifestyle advice; antacids as needed; no investigation required |
| Burning after starting new medication (bisphosphonate, doxycycline, NSAID) | Drug-induced esophagitis | Stop or modify medication; proton pump inhibitor; endoscopy if severe or not improving |
| Retrosternal burning with sour taste, postprandial, relieved by antacids | Gastroesophageal reflux disease | Lifestyle modification; proton pump inhibitor for 4-8 weeks; step down if responsive |
| Burning with exertional component or cardiac risk factors | Must exclude cardiac cause | ECG, troponin if acute; stress testing if stable; treat GERD only after cardiac workup negative |
Algorithm B: Frequent Heartburn (Proton Pump Inhibitor Trial Phase)
| Response to 4-8 Week Proton Pump Inhibitor Trial | Interpretation | Next Step |
|---|---|---|
| Complete symptom resolution (greater than 80% improvement) | Likely acid-related GERD | Step down to lowest effective dose or on-demand therapy; reassess periodically |
| Partial response (50-80% improvement) | Probable GERD with incomplete suppression or overlapping pathology | Optimize proton pump inhibitor (correct timing, consider twice-daily dosing); if still partial, proceed to endoscopy |
| Minimal or no response (less than 50% improvement) | Non-acid reflux, functional heartburn, wrong diagnosis, or non-compliance | Verify compliance and timing; upper endoscopy with biopsies; consider impedance-pH monitoring |
| Initial response then breakthrough symptoms | Nocturnal acid breakthrough, tolerance, or new pathology | Add bedtime histamine-2 receptor antagonist; reassess; endoscopy if persistent |
Algorithm C: Chronic or Refractory Heartburn
| Endoscopy Finding | Diagnosis | Management Pathway |
|---|---|---|
| Erosive esophagitis (Los Angeles Grade A-D) | GERD with mucosal damage | Proton pump inhibitor for 8 weeks; repeat endoscopy for Grade C/D; long-term maintenance therapy |
| Barrett esophagus | Intestinal metaplasia (premalignant) | Continuous proton pump inhibitor; surveillance endoscopy based on dysplasia grade; referral for ablation if dysplasia |
| Eosinophilic esophagitis features with greater than 15 eosinophils per high-power field | Eosinophilic esophagitis | Proton pump inhibitor trial first (proton pump inhibitor-responsive esophageal eosinophilia); if refractory, topical steroids or elimination diet |
| Peptic stricture | Complication of chronic GERD | Endoscopic dilation; continuous proton pump inhibitor therapy; surveillance for recurrence |
| Normal endoscopy with normal biopsies | Non-erosive reflux disease, functional heartburn, or reflux hypersensitivity | Impedance-pH monitoring off proton pump inhibitor to confirm diagnosis; neuromodulators if functional |
| Normal endoscopy, patient on proton pump inhibitor with persistent symptoms | Weakly acidic reflux, non-acid reflux, or functional heartburn | Impedance-pH monitoring on proton pump inhibitor; assess symptom-reflux correlation |
Optimizing Proton Pump Inhibitor Therapy
Before Labeling as “Proton Pump Inhibitor Failure”
Ensure proton pump inhibitor therapy has been optimized:
- Timing: Take 30-60 minutes before the first meal of the day (most important factor)
- Compliance: Daily dosing is essential; as-needed use is less effective for healing
- Dose: Standard dose once daily for most; twice daily for erosive esophagitis, extraesophageal symptoms, or partial responders
- Duration: Minimum 8 weeks for initial trial; some patients need longer
- Switch proton pump inhibitor: If one agent fails, try another (metabolic variability exists)
- Add bedtime histamine-2 receptor antagonist: For nocturnal breakthrough (use intermittently to avoid tolerance)
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient has heartburn but I am concerned about cardiac cause | ECG and troponin (if acute); detailed cardiac history; examine for cardiac signs | If low risk with negative workup, treat GERD; if intermediate or high risk, cardiology referral before assuming gastrointestinal cause |
| Patient has alarm features (dysphagia, weight loss, bleeding) | Do not start empiric therapy; arrange urgent endoscopy | Management based on endoscopic findings; do not delay for proton pump inhibitor trial |
| Patient is over 55 with new-onset symptoms | Arrange endoscopy even without alarm features | Screen for Barrett esophagus and exclude malignancy; may start proton pump inhibitor while awaiting endoscopy |
| Patient has proton pump inhibitor-refractory symptoms despite 8 weeks of therapy | Verify compliance and timing; optimize to twice-daily dosing before meals | If still refractory, upper endoscopy with biopsies; consider impedance-pH monitoring |
| Endoscopy is normal but patient still has symptoms on proton pump inhibitor | Check esophageal biopsies for eosinophilic esophagitis and microscopic esophagitis | Impedance-pH monitoring on proton pump inhibitor; if normal acid exposure and no symptom correlation, diagnose functional heartburn |
| Patient wants to stop long-term proton pump inhibitor | Attempt gradual taper; warn about rebound acid hypersecretion | Step down to lowest effective dose, then alternate-day dosing, then as-needed; some patients will need continuous therapy |
| Patient has nocturnal symptoms despite daytime proton pump inhibitor | Ensure proton pump inhibitor is taken before dinner (second dose); elevate head of bed | Add bedtime histamine-2 receptor antagonist; consider alginate before bed; if persistent, investigate |
| Patient has extraesophageal symptoms (cough, hoarseness) attributed to reflux | Twice-daily proton pump inhibitor for 8-12 weeks (longer trial needed for extraesophageal symptoms) | If no response, diagnosis of reflux-related extraesophageal symptoms is unlikely; pursue other causes |
| Patient is pregnant with troublesome heartburn | Lifestyle modifications first; antacids and alginates are first-line pharmacotherapy | Histamine-2 receptor antagonists if antacids insufficient; proton pump inhibitors (omeprazole has most safety data) for severe symptoms |
| Patient has scleroderma features with severe reflux | High-dose proton pump inhibitor (often twice daily); rheumatology referral for systemic disease | Manometry before any surgical consideration; modified fundoplication only (due to aperistalsis); aggressive acid suppression is mainstay |
Troubleshooting Refractory Heartburn
Systematic Checklist for Refractory Symptoms
- Is the diagnosis correct? Consider cardiac disease, eosinophilic esophagitis, motility disorder, functional heartburn
- Is proton pump inhibitor timing correct? 30-60 minutes before meals is essential
- Is compliance adequate? Daily dosing required; missed doses reduce efficacy
- Is the dose sufficient? Some patients need twice-daily dosing
- Has the duration been adequate? Extraesophageal symptoms may need 12 or more weeks
- Are there persistent triggers? Obesity, dietary factors, medications, smoking
- Is there weakly acidic or non-acid reflux? Impedance-pH monitoring can detect this
- Is there a functional component? Visceral hypersensitivity does not respond to acid suppression
- Are there multiple overlapping causes? GERD plus functional overlay is common
When to Refer to Gastroenterology
| Scenario | Reason for Referral | Urgency |
|---|---|---|
| Alarm features (dysphagia, weight loss, bleeding, anemia) | Endoscopy and further evaluation | Urgent (within 2 weeks) |
| Proton pump inhibitor-refractory symptoms despite optimization | Endoscopy, esophageal function testing, alternative diagnoses | Semi-urgent (within 4-6 weeks) |
| Barrett esophagus identified | Surveillance planning, dysplasia management | Routine (based on dysplasia grade) |
| Consideration for anti-reflux surgery | Preoperative evaluation, surgical candidacy assessment | Routine |
| Suspected eosinophilic esophagitis | Endoscopic confirmation, treatment planning | Semi-urgent |
| Complicated stricture requiring dilation | Therapeutic endoscopy | Based on symptom severity |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Timing is everything for proton pump inhibitors: Taking the medication 30-60 minutes before meals dramatically improves efficacy. A patient who takes their proton pump inhibitor at bedtime or with food may appear “refractory” when they simply need timing correction.
The cardiac mimic: Gastroesophageal reflux disease and cardiac disease frequently coexist. Never assume chest discomfort is “just heartburn” in patients with cardiac risk factors without appropriate evaluation. Both conditions are common and can occur together.
Normal endoscopy does not exclude significant disease: Up to 70% of patients with true GERD have normal endoscopy (non-erosive reflux disease). The absence of erosions does not mean the absence of pathology or that the patient does not need treatment.
Ask about pill-taking habits: Drug-induced esophagitis is preventable. Always ask if patients take medications with a full glass of water and remain upright, especially for bisphosphonates, doxycycline, and potassium supplements.
Weight loss works: Even modest weight reduction (10% of body weight) significantly improves GERD symptoms and may allow reduction or discontinuation of acid suppression. Central adiposity is particularly important.
The young male with dysphagia: Think eosinophilic esophagitis. This increasingly recognized condition presents with heartburn and intermittent dysphagia, often with a history of food impaction and atopic conditions. Always biopsy a normal-appearing esophagus if this is suspected.
Nocturnal symptoms deserve extra attention: Nighttime heartburn is associated with more severe disease, higher risk of complications including Barrett esophagus, and greater impact on quality of life. These patients often need more aggressive therapy.
Left lateral decubitus position helps: Sleeping on the left side reduces nocturnal reflux by keeping the gastroesophageal junction above the gastric acid pool. This simple advice can significantly improve nighttime symptoms.
Critical Pitfalls to Avoid
Assuming all retrosternal burning is gastroesophageal reflux disease: Cardiac disease, eosinophilic esophagitis, esophageal motility disorders, and functional heartburn can all present with similar symptoms. A proton pump inhibitor trial is not a substitute for clinical assessment.
Ignoring alarm features: Dysphagia, weight loss, anemia, and gastrointestinal bleeding require investigation regardless of how “typical” the heartburn seems. Do not delay endoscopy for an empiric proton pump inhibitor trial when alarm features are present.
Labeling patients as “proton pump inhibitor failures” without optimization: Many apparent treatment failures are due to incorrect timing, inadequate duration, or poor compliance. Always verify how and when the medication is taken before escalating therapy or investigation.
Escalating acid suppression indefinitely in non-responders: If a patient does not respond to optimized proton pump inhibitor therapy, more acid suppression is unlikely to help. These patients need investigation and consideration of alternative diagnoses such as functional heartburn.
Missing eosinophilic esophagitis: This condition requires biopsies for diagnosis — the esophagus may appear normal or show only subtle changes. Always take biopsies (minimum 6 from different levels) in patients with dysphagia or proton pump inhibitor-refractory heartburn.
Forgetting medication-induced esophagitis: A detailed medication history is essential. Bisphosphonates, doxycycline, NSAIDs, and potassium chloride are common culprits. The temporal relationship to medication initiation is a key clue.
Attributing all extraesophageal symptoms to reflux: Chronic cough, hoarseness, and asthma have many causes. Reflux is often blamed without adequate evidence. If symptoms do not improve with aggressive acid suppression (8-12 weeks of twice-daily proton pump inhibitor), reflux is unlikely to be the primary cause.
Stopping proton pump inhibitors abruptly after long-term use: Rebound acid hypersecretion can cause symptom flare. Gradual tapering over 2-4 weeks is recommended for patients on long-term therapy who wish to discontinue.
Key Takeaways
- Heartburn is common but not always benign: While most cases are due to uncomplicated GERD, always screen for alarm features that warrant urgent investigation.
- Exclude cardiac disease first: In patients with risk factors or atypical features, cardiac evaluation takes priority over gastrointestinal workup.
- The diagnosis of typical GERD is clinical: Patients without alarm features and under age 55 can be treated empirically with lifestyle modification and proton pump inhibitors.
- Proton pump inhibitor timing is critical: Administration 30-60 minutes before meals optimizes efficacy; incorrect timing is a common cause of apparent treatment failure.
- Normal endoscopy is common in GERD: Up to 70% of patients have non-erosive reflux disease; lack of visible damage does not exclude the diagnosis.
- Proton pump inhibitor-refractory symptoms need investigation: Consider eosinophilic esophagitis, functional heartburn, reflux hypersensitivity, motility disorders, or incorrect diagnosis.
- Always biopsy: Even a normal-appearing esophagus should be biopsied in patients with dysphagia or proton pump inhibitor-refractory symptoms to exclude eosinophilic esophagitis and microscopic abnormalities.
- Lifestyle modifications matter: Weight loss, dietary changes, head-of-bed elevation, and left lateral sleeping position are effective adjuncts to pharmacotherapy.
- Know when to refer: Alarm features, refractory symptoms, Barrett esophagus, and consideration for surgery all warrant gastroenterology consultation.
- Functional heartburn is real: Some patients have normal acid exposure and no symptom-reflux correlation; these patients need neuromodulators, not more acid suppression.
Quick Reference Algorithm
Systematic Approach to Heartburn:
- Assess for alarm features: Dysphagia, weight loss, bleeding, anemia, age greater than 55 with new symptoms → If present, urgent endoscopy
- Exclude cardiac cause: In patients with risk factors or atypical features → ECG, troponin, cardiology evaluation as appropriate
- Start empiric proton pump inhibitor trial: Standard dose, taken 30-60 minutes before breakfast, for 4-8 weeks
- Assess response: Good response supports GERD diagnosis; step down to lowest effective dose
- If refractory: Optimize proton pump inhibitor (timing, twice-daily dosing) → If still refractory, upper endoscopy with biopsies
- If endoscopy normal: Consider impedance-pH monitoring → Diagnose functional heartburn or reflux hypersensitivity if appropriate
- Tailor long-term management: Lifestyle modification, maintenance therapy at lowest effective dose, or neuromodulators for functional disorders
Common Clinical Scenarios: Quick Guide
| Scenario | Key Action | Common Mistake to Avoid |
|---|---|---|
| Typical heartburn, young patient, no alarm features | Lifestyle modification plus empiric proton pump inhibitor | Ordering unnecessary tests before therapeutic trial |
| Heartburn with progressive dysphagia | Urgent endoscopy | Delaying investigation for proton pump inhibitor trial |
| Proton pump inhibitor-refractory after 8 weeks | Optimize timing and dose first, then endoscopy | Escalating dose without verifying compliance and timing |
| Normal endoscopy with persistent symptoms | Impedance-pH monitoring; consider functional diagnosis | Indefinitely increasing acid suppression |
| Young male with heartburn and food impaction history | Endoscopy with biopsies for eosinophilic esophagitis | Assuming GERD without histological evaluation |
| Chronic cough attributed to reflux | 12-week trial of twice-daily proton pump inhibitor | Continuing reflux treatment indefinitely without response |